Lauren Laverne’s diagnosis has put smouldering myeloma in the spotlight – a blood condition doctors watch closely but don’t rush to treat.
Articles on Blood cancer
Displaying all articles
CAR-T cell therapies advance the treatment of cancer, but they are expensive and can take weeks to process. Academic development could cut costs and time while making them more accessible.
A breakthrough therapy is driving aggressive leukaemia into remission. Here’s what the headlines don’t tell you about life after treatment.
Is the taurine in your energy drink a performance booster – or a hidden risk?
The beloved actor says she will be receiving the best treatment available for the stage 4 cancer.
Our team found that chemotherapy can be made more successful by treating nearby ‘normal’ cells with protein-blocking drugs in lymphoma and leukemia.
Writer, broadcaster and commentator Clive James never missed an opportunity to educate his audience. That included raising awareness of leukaemia.
Improvements in survival rates for acute myeloid leukaemia have failed to keep pace with other leukaemias. That may be about to change.
An overview of the most common problems in our blood: bleeding disorders, clotting disorders and cancer.
Top contributors
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Professor of Blood Cancer Research, The University of Queensland
-
Postdoctoral Researcher, University of Aberdeen
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Clinician Scientist and Consultant Haematologist, University of Cambridge
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Lecturer in Nutrition & Exercise Science, University of Westminster
-
Adjunct associate professor, Monash University
-
PhD Candidate in Chemical Engineering, Université Laval